BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Update

BioSyent Inc. (OTCMKTS:BIOYFGet Free Report) saw a large increase in short interest in October. As of October 31st, there was short interest totalling 1,300 shares, an increase of 18.2% from the October 15th total of 1,100 shares. Based on an average daily trading volume, of 1,700 shares, the days-to-cover ratio is currently 0.8 days.

BioSyent Price Performance

OTCMKTS:BIOYF opened at $7.83 on Friday. The company has a 50-day moving average of $8.00 and a 200-day moving average of $7.44. BioSyent has a 52 week low of $5.86 and a 52 week high of $8.90.

BioSyent Increases Dividend

The firm also recently declared a dividend, which was paid on Sunday, September 15th. Shareholders of record on Thursday, September 5th were paid a dividend of $0.0334 per share. This is a boost from BioSyent’s previous dividend of $0.03. The ex-dividend date was Wednesday, September 4th. This represents a yield of 1.72%.

About BioSyent

(Get Free Report)

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.

Recommended Stories

Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.